Home›Sarilumab›Sarilumab + Mao Inhibitors

Does Sarilumab Interact with Mao Inhibitors?

Interaction information. KEVZARA has not been investigated in combination with JAK inhibitors; concomitant use not studied.

Source & how this summary was prepared

This interaction summary was extracted from FDA drug labeling through openFDA, using automated processing and AI assistance. NIH/NLM RxNorm helps organize drug names.

Read the saved source label on DailyMed →

A separate current-label comparison has not been recorded for this page. Read about our extraction process.

Interaction classification: Unknown
Sarilumab Class: Interleukin-6 Receptor Antagonist
Management: Confirm exact products with your pharmacist
Data Source: U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Sarilumab and your doctor is considering prescribing Mao Inhibitors (or vice versa), make sure to:

Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
Ask whether the benefits of combining these medications outweigh the risks for your specific situation
Ask what symptoms to watch for that would indicate the interaction is causing problems
Never stop or change either medication without first consulting your healthcare provider

💊 Sarilumab(Kevzara)+💊 Mao Inhibitors

Severity & Interaction Details

ℹ️

unknown

Interaction information

Read the interaction summary and source below. Use this information to discuss your medication list with your care team.

Severity scale

MinorContra

On record

Yes

Drug A class

Interleukin-6 Receptor Antagonist

Drug B class

—

Source

NLP:sarilumab

What this means in plain English

KEVZARA has not been investigated in combination with JAK inhibitors; concomitant use not studied.

About Sarilumab and Mao Inhibitors

Sarilumab is an Interleukin-6 Receptor Antagonist. Sarilumab is also sold under the brand name Kevzara. Sarilumab additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:sarilumab

Share this result:

WhatsApp Text / SMS Email

Also share on:X Facebook

Add more drugs

Check the medicines you actually take

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

FDA data. NIH drug identities. Plain-language explanations by CDI. Prepared with automated extraction and AI assistance; curated references are identified separately. How we prepare the information · Suggest a correction

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.